Rankings
▼
Calendar
LNTH FY 2021 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena
LNTH
Lantheus Holdings, Inc.
$6B
FY 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$425M
+25.3% YoY
Gross Profit
$188M
44.1% margin
Operating Income
-$61M
-14.3% margin
Net Income
-$71M
-16.8% margin
EPS (Diluted)
$-1.06
Cash Flow
Operating Cash Flow
$54M
Free Cash Flow
$42M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$864M
Total Liabilities
$399M
Stockholders' Equity
$464M
Cash & Equivalents
$99M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$425M
$339M
+25.3%
Gross Profit
$188M
$139M
+35.3%
Operating Income
-$61M
-$4M
-1348.9%
Net Income
-$71M
-$13M
-429.1%
← Q4 2020
All Quarters
Q1 2021 →